Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions

Type 2 diabetes mellitus (T2DM) is significantly associated with oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. This imbalance contributes to insulin resistance, β-cell dysfunction, and complications in organs like the vascul...

Full description

Saved in:
Bibliographic Details
Main Authors: John Dawi, Yura Misakyan, Stephen Affa, Samuel Kades, Ananya Narasimhan, Fouad Hajjar, Max Besser, Kevin Tumanyan, Vishwanath Venketaraman
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/1/18
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589039403794432
author John Dawi
Yura Misakyan
Stephen Affa
Samuel Kades
Ananya Narasimhan
Fouad Hajjar
Max Besser
Kevin Tumanyan
Vishwanath Venketaraman
author_facet John Dawi
Yura Misakyan
Stephen Affa
Samuel Kades
Ananya Narasimhan
Fouad Hajjar
Max Besser
Kevin Tumanyan
Vishwanath Venketaraman
author_sort John Dawi
collection DOAJ
description Type 2 diabetes mellitus (T2DM) is significantly associated with oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. This imbalance contributes to insulin resistance, β-cell dysfunction, and complications in organs like the vasculature and nervous system. Glutathione (GSH), a major antioxidant, is crucial for neutralizing ROS, but GSH levels are notably low in T2DM, exacerbating oxidative stress and inflammation. Elevated interleukin-6 (IL-6) levels further intensify inflammation and oxidative stress, disrupting insulin signaling and worsening complications such as nephropathy, retinopathy, and neuropathy. While lifestyle modifications and antioxidant supplementation are current approaches for managing oxidative stress, their effectiveness in preventing complications remains under study. Recent investigations suggest that GSH and Vitamin D3 supplementation may offer dual-action benefits, as Vitamin D3 not only has anti-inflammatory properties but also promotes GSH synthesis. This dual action helps mitigate both oxidative stress and inflammation, addressing key pathological features of T2DM. This review highlights the complex interactions between oxidative stress, GSH insufficiency, and IL-6, and emphasizes the potential of targeted therapies to improve the management and outcomes of T2DM.
format Article
id doaj-art-48257f96c5da4f76b88dbd86e41cae43
institution Kabale University
issn 2227-9059
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-48257f96c5da4f76b88dbd86e41cae432025-01-24T13:23:44ZengMDPI AGBiomedicines2227-90592024-12-011311810.3390/biomedicines13010018Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic InterventionsJohn Dawi0Yura Misakyan1Stephen Affa2Samuel Kades3Ananya Narasimhan4Fouad Hajjar5Max Besser6Kevin Tumanyan7Vishwanath Venketaraman8College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USADepartment of Chemistry, Physics, and Engineering, Los Angeles Valley College, Valley Glen, CA 91401, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USACollege of Podiatric Medicine, Western University of Health Sciences, Pomona, CA 91766, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USAType 2 diabetes mellitus (T2DM) is significantly associated with oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. This imbalance contributes to insulin resistance, β-cell dysfunction, and complications in organs like the vasculature and nervous system. Glutathione (GSH), a major antioxidant, is crucial for neutralizing ROS, but GSH levels are notably low in T2DM, exacerbating oxidative stress and inflammation. Elevated interleukin-6 (IL-6) levels further intensify inflammation and oxidative stress, disrupting insulin signaling and worsening complications such as nephropathy, retinopathy, and neuropathy. While lifestyle modifications and antioxidant supplementation are current approaches for managing oxidative stress, their effectiveness in preventing complications remains under study. Recent investigations suggest that GSH and Vitamin D3 supplementation may offer dual-action benefits, as Vitamin D3 not only has anti-inflammatory properties but also promotes GSH synthesis. This dual action helps mitigate both oxidative stress and inflammation, addressing key pathological features of T2DM. This review highlights the complex interactions between oxidative stress, GSH insufficiency, and IL-6, and emphasizes the potential of targeted therapies to improve the management and outcomes of T2DM.https://www.mdpi.com/2227-9059/13/1/18T2DMGSHROSVitamin D3IL-6β-cells
spellingShingle John Dawi
Yura Misakyan
Stephen Affa
Samuel Kades
Ananya Narasimhan
Fouad Hajjar
Max Besser
Kevin Tumanyan
Vishwanath Venketaraman
Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
Biomedicines
T2DM
GSH
ROS
Vitamin D3
IL-6
β-cells
title Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
title_full Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
title_fullStr Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
title_full_unstemmed Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
title_short Oxidative Stress, Glutathione Insufficiency, and Inflammatory Pathways in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
title_sort oxidative stress glutathione insufficiency and inflammatory pathways in type 2 diabetes mellitus implications for therapeutic interventions
topic T2DM
GSH
ROS
Vitamin D3
IL-6
β-cells
url https://www.mdpi.com/2227-9059/13/1/18
work_keys_str_mv AT johndawi oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT yuramisakyan oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT stephenaffa oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT samuelkades oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT ananyanarasimhan oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT fouadhajjar oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT maxbesser oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT kevintumanyan oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions
AT vishwanathvenketaraman oxidativestressglutathioneinsufficiencyandinflammatorypathwaysintype2diabetesmellitusimplicationsfortherapeuticinterventions